aspirin has been researched along with Communicable Diseases in 4 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Communicable Diseases: An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Acute inflammation of the vasculature, genetic susceptibility and immunopathogenesis based on a transmittable and infectious origin, are the pathologic events involved in the early inflammatory etiology and progression of this disease." | 5.48 | Melatonin: A hypothesis for Kawasaki disease treatment. ( Gil-Martín, E; López-Muñoz, F; Patiño, P; Ramos, E; Reiter, RJ; Romero, A, 2018) |
| "Acute inflammation of the vasculature, genetic susceptibility and immunopathogenesis based on a transmittable and infectious origin, are the pathologic events involved in the early inflammatory etiology and progression of this disease." | 1.48 | Melatonin: A hypothesis for Kawasaki disease treatment. ( Gil-Martín, E; López-Muñoz, F; Patiño, P; Ramos, E; Reiter, RJ; Romero, A, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ramos, E | 1 |
| Patiño, P | 1 |
| Reiter, RJ | 1 |
| Gil-Martín, E | 1 |
| López-Muñoz, F | 1 |
| Romero, A | 1 |
| Windgassen, EB | 1 |
| Funtowicz, L | 1 |
| Lunsford, TN | 1 |
| Harris, LA | 1 |
| Mulvagh, SL | 1 |
| THUAU, F | 1 |
| Burgner, D | 1 |
| Harnden, A | 1 |
2 reviews available for aspirin and Communicable Diseases
| Article | Year |
|---|---|
C-reactive protein and high-sensitivity C-reactive protein: an update for clinicians.
Topics: Aspirin; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Communicable Diseases; Gastrointes | 2011 |
Kawasaki disease: what is the epidemiology telling us about the etiology?
Topics: Air Pollutants; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bacterial Infections; Child; Commu | 2005 |
2 other studies available for aspirin and Communicable Diseases
| Article | Year |
|---|---|
Melatonin: A hypothesis for Kawasaki disease treatment.
Topics: Anti-Inflammatory Agents; Aspirin; Child; Child, Preschool; Communicable Diseases; Genetic Predispos | 2018 |
[TH-2152 APROPOS OF SOME CLINICAL EXPERIMENTATION IN THE INFECTIOUS DISEASES AND RESUSCITATION DEPARTMENT OF THE CENTRE HOSPITALIER UNIVERSITAIRE D'ANGERS].
Topics: Analgesia; Anger; Aspirin; Bicarbonates; Biomedical Research; Communicable Diseases; Pain; Resuscita | 1964 |